Skip to main content

Health

CDC's Collaboration with Academia to Strengthen Public Health Workforce Capacity

The purpose of this Notice of Funding Opportunity (NOFO) is to support the applicant's management of domestic fellowships for students or recent graduates of CEPH-accredited schools or programs of public health or CCNE-accredited baccalaureate and higher degree colleges of nursing. Fellowships and other similar experiential placements are vital to CDC's strategic interests to ensure students and emerging health professionals receive adequate hand-on experience in public health practice at CDC's domestic offices, at state, tribal, local, and territorial health departments, and at other community-based settings. For the purposes of this NOFO, fellowships are for recent graduates within five years of graduation. The overall goal is to create the opportunities for academia to develop qualified, knowledgeable and experienced students and emerging health professionals suitably prepared to serve in governmental public health practice, or able to apply public health concepts in various healthcare or other settings, to collectively meet the challenge of improving the population’s health.

Application Due : April 12, 2018

Center for Research on Hispanic Children and Families

The Office of Planning, Research and Evaluation (OPRE) within the Administration for Children and Families (ACF) is considering soliciting applications for a Center for Research on Hispanic Children and Families, to lead and support investigation of the needs of Hispanic populations served by ACF and promising approaches to promote social and economic well-being among low-income Hispanic families. This research center (hereafter referred to as "Center") would ideally bring together a diverse, interdisciplinary team of academic and organizational partners to provide leadership in culturally competent research that can inform policies concerning low-income Hispanic families and to foster significant scholarship regarding the needs and experiences of the diverse Hispanic populations throughout the nation.

Application Due : Jun 15, 2018

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)

The purpose of this Kirschstein-NRSA predoctoral fellowship (F31) award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from population groups that have been shown to be underrepresented in the biomedical, behavioral, or clinical research workforce, including underrepresented racial and ethnic groups and those with disabilities. Through this award program, promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting well-defined research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist

Application Due : April 8, 2018

Collaborative Improvement and Innovation Network on School-Based Health Services

The purpose of the Collaborative Improvement and Innovation Network on School-Based Health Services (CoIIN-SBHS) cooperative agreement program is to improve children’s and adolescents’ access to high quality, comprehensive health care through the expanded use of evidence-based models of school-based health (SBH) services, including SBH centers and comprehensive school mental health systems (CSMHSs). The intent of the CoIIN-SBHS is to improve the quality of SBH centers and CSMHSs, and to enhance the sustainability and growth of these models of SBH services across the nation and in urban, suburban, and rural settings.

Application Due : April 18,2018

National Research Mentoring Network (NRMN) Resource Center (U24 - Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from qualified institutions for the NIH National Research Mentoring Network (NRMN) Resource Center. The NRMN is a nationwide consortium intended to enhance the training and career development of biomedical researchers from diverse backgrounds, through enhanced networking and mentorship experiences. One grant will be awarded for the development and management of a NRMN Resource Center, which will provide a web-based mentoring tool to facilitate real-time mentor/mentee engagement and networking. The awardee will also oversee the management of the NRMN website, report on outputs from NRMN components, and serve as a repository for publicly available mentoring resources and tools.

Application Due : June 11,2018

National Research Mentoring Network (NRMN) Coordination Center (U24 - Clinical Trial Not Allowed)

The National Research Mentoring Network (NRMN) is a nationwide consortium developed to enhance the training and career development of individuals from diverse backgrounds who are pursuing biomedical research careers by providing networking and mentorship experiences. The NRMN Coordination Center will provide infrastructure and expertise that supports the collection, secure storage, and reporting of data generated by the individual NRMN component projects. Building upon the instruments and processes developed to assess the impact of NRMN activities in the previous Diversity Program Consortium (DPC) funding period, the NRMN Coordination Center will coordinate the early stages of collection of data in an ongoing way, and provide feedback to the consortium to maximize the research benefit of the various NRMN activities. The NRMN Coordination Center will also be responsible for promoting synergistic interactions with the DPC Center for Evaluation and Coordination (CEC) for the long-term collection and storage of data.

Application Due : June 11,2018

National Research Mentoring Network: The Science of Mentoring, Networking, and Navigating Career Transition Points (U01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the second phase of the NIH National Research Mentoring Network (NRMN) efforts. The NRMN is a nationwide consortium that was designed to enhance mentoring and career development of individuals from groups underrepresented in the biomedical research workforce. This new cycle of NRMN will expand the scientific scope of the program to encourage grants with varied approaches aimed at the science of mentorship, networking, and navigating critical career transition points. The NRMN will be a set of cooperative agreements in which the Program Directors/Principal Investigators (PDs/PIs) will work through a NRMN Coordination Center and the NRMN Resource Center to disseminate effective resources. The NRMN research is expected to align with the hallmarks of success that have been defined by the Diversity Program Consortium and the Center for Evaluation and Coordination (CEC).

Application Due : June 11,2018

Paralysis Resource Center State Pilot Program

ACL intends to award up to five (5) Paralysis Resource Center (PRC) State Pilot Program grants designed to enhance the capacity of community disability-based programming by improving and/or increasing the services and supports provided by community-based disability organizations that are working to improve the quality of life for individuals living with paralysis, their families, and their caregivers. Grantees funded under this three year announcement will make subawards to community-based organizations across their states that provide long-term services and supports to people living with paralysis. All activities funded under this grant will promote greater independence, equality, choice, and control for individuals living with paralysis and to help them more fully integrate into their communities.Under a separate 2018 funding opportunity announcement, ACL will also award funds for a National Paralysis Resource Center (NPRC).

Application Due : April 17,2018

National Paralysis Resource Center

ACL intends to award funds to support one (1) National Paralysis Resource Center (NPRC) that will improve the health and quality of life of individuals living with paralysis of all ages, their families, and their caregivers by raising awareness of and facilitating access to a broad range of services relevant to individuals with paralysis over the next three years. The NPRC will work with ACL and ACL-funded programs to remove environmental barriers to health and community living for individuals living with paralysis, their families, and their caregivers. The NPRC will operate a national resource and information center, make subawards to nonprofit community-based organizations that provide long-term services and supports to people living with paralysis, conduct promotional activities and outreach, increase support and resources available to people living with paralysis, their families and caregivers and provide performance measures. 

Application Due : April 17,2018

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required

The purpose of this Funding Opportunity Announcement (FOA) is to solicit UG3/UH3 phased cooperative agreement research applications to plan and implement behavioral and social intervention clinical trials. Studies appropriate for this announcement include traditional clinical trials meant to develop and test behavior change interventions meant to prevent or treat dental, oral, or craniofacial conditions, as well as interventions that are used as tools to understand mechanisms of behavior change. Awards made under this FOA will initially support a milestone-driven planning phase (UG3) for up to 2 years, with possible transition to a clinical trial implementation phase of up to five years (UH3). Only UG3 projects that have met the scientific milestones and feasibility requirements may transition to the UH3 phase.

Application Due : Jan 07, 2021

 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutical-based agents, and pesticides. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy consistent with the product's intended use in humans.

Application Due : Sep 09, 2020

NIAMS Skin Biology and Diseases Resource-based Centers (P30)

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for skin biology and diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Application Due : Jun 11, 2018

Limited Competition for the Continuation of the Clinical Centers for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (U01 Clinical Trial Not Allowed )

This Limited Competition Funding Opportunity Announcement (FOA) invites applications from the Program Directors/Principal Investigators of the six current Clinical Centers (CCs) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study of Type 1 Diabetes (T1D) etiology. The TEDDY study involves the rigorous investigation of TEDDY subjects, collecting data and samples, for the identification of infectious agents, dietary factors, or other environmental factors associated with onset of T1D and/or T1D associated autoimmune markers. The six current CCs have been involved in study design and data and biosample acquisition since the inception of the TEDDY consortium. The CCs have recruited participants and followed the subjects over the past 15 years.

Application Due : Apr 10, 2018

Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed)

The purpose of this initiative is to support time-sensitive research on risk and resilience factors related to short- and long-term health outcomes following Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands. In order for research projects to address risk and resilience in the immediate aftermath and/or recovery period after the recent hurricanes, this initiative will use a shortened submission timeline with expedited peer review, council concurrence and award issuance. The entire cycle, from submission to award, is expected to be within 3-4 months.

Application Due : Apr 16, 2018

Substance Abuse Treatment for Children and Adolescents

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Center for Substance Abuse Treatment (CSAT) is accepting applications for fiscal year (FY) 2018 Enhancement and Expansion of Treatment and Recovery Services for Adolescents, Transitional Aged Youth, and their Families grant program (Short Title: Youth and Family TREE). The purpose of this program is to enhance and expand comprehensive treatment, early intervention, and recovery support services for adolescents (ages 12-18), transitional aged youth (ages 16-25), and their families/primary caregivers with substance use disorders (SUD) and/or co-occurring substance use and mental disorders.

Application Due : Apr 10, 2018

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Application Due : Jan 07, 2021

Notice of Intent to Publish a Funding Opportunity Announcement for A Practice-Based Research Network to Transform Mental Health Care: Science, Service Delivery & Sustainability (U19 Clinical Trial Required)

The NIMH intends to publish a Funding Opportunity Announcement (FOA) Cooperative Agreement (U19) to solicit applications for a practice-based research network to transform mental health care.   The planned FOA will support a practice-based research network in the United States to transform the development, delivery, and sustainability of evidence-based mental health practices and services. Through a research consortium embedded within large and integrated healthcare delivery systems, this Network would result in a continuously learning healthcare system as defined by the Institute of Medicine, to create “a continuous cycle or feedback loop in which scientific evidence informs clinical practice while data gathered from clinical practice and administrative sources inform scientific investigation.

Application Due : June 01, 2018

Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs and foster a better understanding of biomedical, behavioral and clinical research and its implications.

Application Due : June 29, 2018

Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)

The Shared Instrumentation for Animal Research (SIFAR) Grant Program encourages applications from groups of NIH-funded investigators to purchase or upgrade scientific instruments necessary to carry out animal experiments in all areas of biomedical research supported by the NIH. Applicants may request clusters of commercially available instruments configured as specialized integrated systems or as series of instruments to support a thematic well-defined area of research using animals or related materials. Priority will be given to uniquely configured systems to support innovative and potentially transformative investigations. This FOA supports requests for state-of-the art commercially available technologies needed for NIH-funded research using any vertebrate and invertebrate animal species. This funding opportunity announcement (FOA) does not support requests for single instruments. At least one item of the requested instrumentation must cost at least $50,000, after all applicable discounts. No instrument in a cluster can cost less than $20,000, after all applicable discounts. There is no maximum price requirement; however, the maximum award is $750,000.

Application Due : May 31, 2018

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

The Shared Instrument Grant (SIG) Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. The minimum award is $50,000. There is no maximum price requirement; however, the maximum award is $600,000. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass and nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.

Application Due : May 31, 2018

High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)

The High-End Instrumentation (HEI) Grant Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,001. The maximum award is $2,000,000. Types of instruments supported include, but are not limited to: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers.

Application Due : May 31, 2018

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project.

Application Due : Sep 07, 2021

Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that propose to develop and validate cell- and tissue-based platforms for assessing potential adverse biological consequences of somatic cell genome editing.

Application Due : April 03, 2018

NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)

In the context of this program, an expert assembles a multi-disciplinary research team that uses an integrative approach to develop rapid and efficient translation of innovative laboratory research findings into therapies, devices or other resources for use by clinicians to treat visual system diseases or disorders. It involves collaborative teams of scientists and clinicians with expertise in multiple disciplines, operating according to a clear leadership plan. Such a collaborative approach is particularly appropriate for research focused on pathways that will likely be targeted by biological intervention, such as gene therapy, cell-based therapy, pharmacological approaches, and the development and use of medical devices. 

Application Due : March 27, 2019

Obesity Policy Evaluation Research (R01)

This Funding Opportunity Announcement (FOA) encourages applications that propose to evaluate policies or large scale programs that are expected to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes have the potential to prevent or reduce rates of obesity. 

Application Due : June 5, 2018

Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this Fogarty International Center R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs by enhancing health workforce capacity in high HIV-burden, low-income countriesin sub-Saharan Africa; enhance the diversity of the biomedical, behavioral and clinical research workforce by encouraging interprofessional education initiatives to enhance team health care delivery; help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences in low-income countries to enhance capacity of US research projects; foster a better understanding of biomedical, behavioral and clinical research and its implications to improve capacity to develop, implement and evaluate evidence-based health services.

Application Due : Mar 28, 2018

 

 

BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed)

This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, aims to support full development of entirely new or next generation noninvasive human brain imaging tools and methods that will lead to transformative advances in our understanding of the human brain. The FOA seeks innovative applications that are ready for full-scale development of breakthrough technologies with the intention of delivering working tools within the timeframe of the BRAIN Initiative (BRAIN 2025: A Scientific Vision, http://braininitiative.nih.gov/). This FOA represents the second stage of the tool/technology development effort that started with RFA-MH-14-217 and RFA-MH-15-200

Application Due : Dec 11, 2018

Notice of Intent to Publish a Funding Opportunity Announcement for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)

​The National Institute of Neurological Disorders and Stroke (NINDS), intends to re-issue a Program Announcement with Special Review Considerations (PAR) to solicit applications for "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)". The goal of this initiative is to provide support for translational research to develop therapeutics for reducing mortality and morbidity caused by acute exposures to chemical threat agents. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy consistent with the product's intended use in humans. 

Application Due : Sep 01, 2018

 

 

 

 Department of Defense

 

White Paper: This BAA is open and effective through 1 March 2021 at 5:00 pm Local Time, WrightPatterson Air Force Base. White papers may be submitted at any time during this period.

Proposal: To be provided in response to the Requests for Proposals sent to offerors that submit White Papers considered to meet the needs of the Air Force.

The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer. Although not required, investigators are encouraged to address one of the FY17 Areas of Encouragement in their applications.

Full Application: TBD

Breast Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2017
Due to the current Continuing Resolution, the Fiscal Year 2017 (FY17) Defense Appropriations bill has not been passed. Although funds have not been appropriated for the Department of Defense Breast Cancer Research Program (BCRP), the BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
Full Application: TBD

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) Research and Development Directorate (J9) manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
Pre-Application: varies
Full Application:varies

Cancer Prevention and Research Institute of Texas

 

 

 

 

 

American Association for Cancer Research 

NASA

2017 NASA HERO NRA

This National Aeronautics and Space Administration (NASA) Research Announcement (NRA), entitled Human Exploration Research Opportunities (HERO)–2017, solicits research in support of NASA’s Human Research Program (HRP). The HRP contains six Elements: Space Radiation, Human Health and Countermeasures, Exploration Medical Capability, Behavioral Health and Performance, Space Human Factors and Habitability, and International Space Station Medical Project. Fourteen disciplines or areas support the Program: Behavioral Health and Performance, Bone, Cardiovascular, Extravehicular Activity, Immunology, Medical Capabilities, Muscle, Nutrition, Pharmacology, Radiation, Sensorimotor, Advanced Food Technology, Advanced Environmental Health, and Space Human Factors Engineering. Awards generally range from under $100K per year for focused, limited efforts (e.g., data analysis) to $1M per year for extensive activities (e.g., development of scientific hardware). The funds available for awards in each program element offered in this solicitation range from less than one to several million dollars, which allows NASA to select a few to numerous proposals depending on the program objectives and the submission of proposals of merit. This solicitation may result in grant, cooperative agreement, and contract awards. 

Deadlines vary. See http://nspires.nasaprs.com/ for more information.

Patient-Centered Outcomes Research Institute (PCORI)